Showing results (101-110 of 119) with videos related to
Sort By:
Pageof 12
Blood Cancer Discovery|June 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell LymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCLLaura K Hilton, Henry S Ngu, Brett Collinge, et al.Blood|June 20, 2025
Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell LymphomaShinya Rai, Gerben Duns, Fabian Frontzek, et al.Blood Advances|July 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatmentMalgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2023
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K Hilton, Henry S Ngu, Brett Collinge, et al.The Journal of Clinical Investigation|March 19, 2024
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosingJacob Appelbaum, April E Price, Kaori Oda, et al.Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP studyBrett Collinge, Laura K Hilton, Jasper Wong, et al.Nature Communications|October 3, 2018
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphomaSarah E Arthur, Aixiang Jiang, Bruno M Grande, et al.Blood Advances|July 17, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP studyBrett J Collinge, Laura K Hilton, Jasper Chun Hei Wong, et al.Pageof 12